Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.
Today we look at two noteworthy recent insider buys.
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.
Today we look at two noteworthy recent insider buys.
On Monday, Vertex Pharmaceuticals's Director, Bruce I.
Sachs, made a $2.97M buy of VRTX, purchasing 15,000 shares at a cost of $197.91 a piece.
So far Sachs is in the green, up about 2.1% on their purchase based on today's trading high of $202.16.
Vertex Pharmaceuticals, is trading up about 0.9% on the day Thursday.
Before this latest buy, Sachs made one other buy in the past twelve months, purchasing $3.26M shares for a cost of $217.36 each.
And at Traeger, there was insider buying on Monday, by Director Elizabeth Cahill Lempres who purchased 31,250 shares for a cost of $18.00 each, for a total investment of $562,500.
Traeger Inc is trading up about 4.7% on the day Thursday.
So far Lempres is in the green, up about 70.8% on their purchase based on today's trading high of $30.75.